Appsilon is a leading technology company that partners with top life sciences organizations to deliver open-source solutions in R and Python, deploy Statistical Computing Environments (SCEs) on cloud-native platforms, and support SAS-to-R migration for faster, data-driven decision-making in regulated settings. The company specializes in accelerating drug development through advanced data visualizations, validated statistical computing environments, and R package validation services. Eight out of the ten largest pharmaceutical companies use Appsilon services, including major brands like Merck, Johnson & Johnson, and Genmab.
Founded in 2013, Appsilon has established itself as a Posit (formerly RStudio) Full Service Certified Partner and recognized contributor to the open-source community. The company has been named one of Europe's fastest-growing companies in The Financial Times 1000 for two consecutive years. Appsilon combines software excellence, AI innovation, and cloud infrastructure expertise to deliver solutions that reduce critical app response times from minutes to seconds, generate significant annual savings for clients, and accelerate clinical data app deployment. Their team of world-class talent is selected from 15,000+ applicants annually, with only 1% making the cut, ensuring the highest quality delivery for complex life sciences projects.
